All trial receipts are passcode-locked. Pick a receipt below to unlock the full de-risking map and ledger case file.
Was /target-validation → now /ledger/ceacam5/
/target-validation
/ledger/ceacam5/
CEACAM5-DM4 ADC // Dual-Gate Patient Selection Strategy
Unlock trial receipt →
Was /resistance → now /ledger/capri/
/resistance
/ledger/capri/
Ceralasertib (ATRi) + Olaparib (PARPi) // AZ Phase II HGSOC
Was /moa → now /ledger/latify/
/moa
/ledger/latify/
Ceralasertib (ATRi) + Durvalumab (PD-L1) // AZ Phase III NSCLC failure
NCT05450692 · IO-refractory NSCLC
NCT04154956 · NSCLC (CARMEN-LC03) / MSS mCRC expansion (inference)
NCT02264678 · Recurrent HGSOC
NCT03579316 · Recurrent solid tumors (ovarian focus)
/ledger/adavosertib/
NCT02595892 · Platinum-resistant ovarian carcinoma
/ledger/berzosertib/
DE-RISKING RECEIPT: 2026_03_24_V2 // LOCKED FOR AUDIT